Answers are grounded in this paper and cite their sources.
Purpose We evaluated changes in visual and anatomic outcomes in patients with difficult-to-treat wet age-related macular degeneration (wAMD) who were switched to faricimab from brolucizumab. Methods We conducted an IRB-approved retrospective chart review of patients with wAMD treated at Retinal Consultants P.C. across five clinical sites between July 2020 and May 2024. Patients with ambiguous diagnoses, a history of endophthalmitis or inflammatory disorders, surgery or photodynamic therapy, inadequate follow-up, or who did not receive the two drugs of interest sequentially were excluded. Best corrected visual acuity (BCVA), central subfield thickness (CST), and retinal fluid assessment were recorded for each treatment period and compared between faricimab and brolucizumab. Wilcoxon’s signed-rank tests and McNemar’s tests were used to assess significance. Results 57 eyes were included. All patients had persistent or recurrent retinal fluid despite treatment with anti-VEGF therapy prior to initiating brolucizumab. Patients received a mean of 9.6 ± 4.9 IVB injections and 8.6 ± 6.6 IVF injections, with a mean treatment duration of 52.7 ± 35.9 and 59.3 ± 31.5 weeks for brolucizumab and faricimab, respectively. Neither BCVA or CST changed significantly from baseline following treatment with either agent. Average BCVA and CST were comparable on both IVB and IVF. However, complete fluid resolution occurred more frequently with faricimab than brolucizumab (p = 0.01). Treating retina specialists reported 75.4% of eyes had an improved response to faricimab. Conclusions Switching from brolucizumab to faricimab resulted in similar reductions in CST and BCVA, with higher rates of fluid resolution. These findings suggest that faricimab may serve as an effective alternative for patients who remain on brolucizumab with a history of treatment resistance.
No takes yet. Share an insight, caveat, or question.
Prince et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: